Trial intelligence / Profile preview

Growth Hormone Treatment in Children with X-Linked Hypophosphatemic Rickets

NCT02720770Phase 2Completed

Sponsor
Hôpital Bicêtre
Start
Jan 2006
Primary completion
Jan 2009
Modality
Hormone, rProtein (Recombinant Protein), Biologic
01

Overview

A Phase 2 trial of somatropin in X-linked hypophosphatemic rickets (XLH), sponsored by Hôpital Bicêtre. Started Jan 2006; status: completed.

02

Drugs

somatropin
03

Conditions

X-linked hypophosphatemic rickets (XLH)

Beyond the preview

Go deeper on NCT02720770.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02720770.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call